- Home
- GDTC vs ANGH Comparison
GDTC vs ANGH Comparison
Compare GDTC & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- ANGH
- Stock Information
- Founded
- GDTC 2018
- ANGH 2012
- Country
- GDTC Singapore
- ANGH United Arab Emirates
- Employees
- GDTC N/A
- ANGH N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- ANGH Telecommunications Equipment
- Sector
- GDTC Health Care
- ANGH Consumer Discretionary
- Exchange
- GDTC Nasdaq
- ANGH Nasdaq
- Market Cap
- GDTC 21.5M
- ANGH 32.1M
- IPO Year
- GDTC 2023
- ANGH N/A
- Fundamental
- Price
- GDTC $1.89
- ANGH $0.41
- Analyst Decision
- GDTC Buy
- ANGH
- Analyst Count
- GDTC 1
- ANGH 0
- Target Price
- GDTC $5.00
- ANGH N/A
- AVG Volume (30 Days)
- GDTC 18.1K
- ANGH 2.8M
- Earning Date
- GDTC 01-01-0001
- ANGH 08-05-2025
- Dividend Yield
- GDTC N/A
- ANGH N/A
- EPS Growth
- GDTC N/A
- ANGH N/A
- EPS
- GDTC N/A
- ANGH N/A
- Revenue
- GDTC $368,838.00
- ANGH $78,093,405.00
- Revenue This Year
- GDTC $5.37
- ANGH N/A
- Revenue Next Year
- GDTC N/A
- ANGH N/A
- P/E Ratio
- GDTC N/A
- ANGH N/A
- Revenue Growth
- GDTC N/A
- ANGH 88.72
- 52 Week Low
- GDTC $1.20
- ANGH $0.40
- 52 Week High
- GDTC $4.05
- ANGH $0.98
- Technical
- Relative Strength Index (RSI)
- GDTC 37.08
- ANGH 41.92
- Support Level
- GDTC $1.85
- ANGH $0.44
- Resistance Level
- GDTC $1.95
- ANGH $0.71
- Average True Range (ATR)
- GDTC 0.10
- ANGH 0.08
- MACD
- GDTC -0.02
- ANGH -0.00
- Stochastic Oscillator
- GDTC 28.00
- ANGH 1.87
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.